Shareholding20 Jul 2026, 07:41 pm
Suven Life Sciences Shareholding Diluted Post ESOP & Warrant Conversion
AI Summary
Jasti Property and Equity Holdings Pvt Ltd & PACs have disclosed a change in their shareholding in Suven Life Sciences Limited. The dilution occurred due to the allotment of 2,71,970 equity shares via ESOP exercise and 1,85,70,133 equity shares from preferential allotment upon warrant conversion. Consequently, their shareholding has decreased from 70.15% to 65.47% of the total voting share capital. The total equity share capital of Suven Life Sciences has increased to 28,25,62,686 shares.
Key Highlights
- Promoter group shareholding in Suven Life Sciences diluted to 65.47%.
- Dilution resulted from ESOP exercise and warrant conversion.
- 2,71,970 shares issued via ESOPs.
- 1,85,70,133 shares issued via preferential allotment.
- Total equity share capital increased significantly.
Price Impact
More from SUVEN